Cardiovascular Implantable Devices Market Research Report –Segmentation by Device Type (Cardiac Rhythm Management (CRM) Devices (Pacemakers, Implantable Cardioverter Defibrillators), Coronary Stents (Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Scaffolds), Structural Heart Devices (TAVR/TAVI, Heart Valves, Closure Devices), Cardiac Assist Devices (Ventricular Assist Devices, Total Artificial Heart), Implantable Cardiac Monitors (Insertable Loop Recorders), Others); by Procedure Type (Minimally Invasive Procedures, Open Surgical Procedures, Transcatheter Procedures, Hybrid Procedures, Others); by Material Type (Metal-Based Implants, Polymer-Based Implants, Biological/Tissue-Based Implants, Composite/Hybrid Materials, Others); by Indication (Arrhythmia Management, Coronary Artery Disease, Heart Failure, Structural Heart Defects, Others); by End User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgical Centers (ASCs), Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)